RU2069662C1 - Производные пиразоло [1,5-а] пиридина, или их фармацевтически приемлемые соли и способ их получения - Google Patents

Производные пиразоло [1,5-а] пиридина, или их фармацевтически приемлемые соли и способ их получения Download PDF

Info

Publication number
RU2069662C1
RU2069662C1 SU5011507/04A SU5011507A RU2069662C1 RU 2069662 C1 RU2069662 C1 RU 2069662C1 SU 5011507/04 A SU5011507/04 A SU 5011507/04A SU 5011507 A SU5011507 A SU 5011507A RU 2069662 C1 RU2069662 C1 RU 2069662C1
Authority
RU
Russia
Prior art keywords
alkyl
carboxy
compound
acid
salt
Prior art date
Application number
SU5011507/04A
Other languages
English (en)
Russian (ru)
Inventor
Сиокава Еуити
Jp]
Акахане Атсуси
Катаяма Хирохито
Митсунага Такафуми
Ката ма Хирохито
Original Assignee
Фудзисава Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фудзисава Фармасьютикал Ко., Лтд. filed Critical Фудзисава Фармасьютикал Ко., Лтд.
Application granted granted Critical
Publication of RU2069662C1 publication Critical patent/RU2069662C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)
SU5011507/04A 1991-04-10 1992-04-09 Производные пиразоло [1,5-а] пиридина, или их фармацевтически приемлемые соли и способ их получения RU2069662C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9107513.5 1991-04-10
GB919107513A GB9107513D0 (en) 1991-04-10 1991-04-10 Pyrazolopyridine compound and processes for preparation thereof

Publications (1)

Publication Number Publication Date
RU2069662C1 true RU2069662C1 (ru) 1996-11-27

Family

ID=10692949

Family Applications (1)

Application Number Title Priority Date Filing Date
SU5011507/04A RU2069662C1 (ru) 1991-04-10 1992-04-09 Производные пиразоло [1,5-а] пиридина, или их фармацевтически приемлемые соли и способ их получения

Country Status (23)

Country Link
US (1) US5234930A (enExample)
EP (1) EP0516941B1 (enExample)
JP (2) JP2546470B2 (enExample)
KR (1) KR100248700B1 (enExample)
CN (2) CN100508975C (enExample)
AT (1) ATE146473T1 (enExample)
AU (1) AU653007B2 (enExample)
CA (1) CA2065644C (enExample)
DE (1) DE69215965T2 (enExample)
DK (1) DK0516941T3 (enExample)
ES (1) ES2095976T3 (enExample)
FI (1) FI100969B (enExample)
GB (1) GB9107513D0 (enExample)
GR (1) GR3022113T3 (enExample)
HU (2) HU214871B (enExample)
IE (1) IE921086A1 (enExample)
IL (1) IL101544A (enExample)
MX (1) MX9201672A (enExample)
NO (1) NO300271B1 (enExample)
RU (1) RU2069662C1 (enExample)
SG (1) SG43917A1 (enExample)
TW (1) TW205550B (enExample)
UA (1) UA27252C2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2235725C2 (ru) * 1998-04-29 2004-09-10 Астразенека Аб Производные имидазопиридина, способ их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты и способ лечения состояний, в которые вовлечено инфицирование h.pylori

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541213A (en) * 1993-06-24 1996-07-30 Eisai Co., Ltd. Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility
EP0737193A1 (en) * 1993-12-29 1996-10-16 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine adenosine antagonists
WO1997040047A1 (en) * 1996-04-25 1997-10-30 Fujisawa Pharmaceutical Co., Ltd. Preventives and remedies for ischemic intestinal lesion and ileus
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0972525A4 (en) * 1997-03-18 2000-11-29 Fujisawa Pharmaceutical Co PREVENTIVE AND HEALING AGENTS AGAINST HYPERPHOSPHATEMIA
EP1084710B1 (en) * 1998-06-01 2006-10-18 Astellas Pharma Inc. Adenosine a1 antagonists for male sterility
US20040152659A1 (en) * 1999-05-12 2004-08-05 Fujisawa Pharmaceutical Co. Ltd. Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
AU2002239348A1 (en) * 2000-12-15 2002-06-24 Glaxo Group Limited Pyrazolopyridine derivatives
ATE301653T1 (de) * 2000-12-15 2005-08-15 Glaxo Group Ltd Pyrazolopyridine
DE60201074T2 (de) * 2001-03-08 2005-09-15 Smithkline Beecham Corp. Pyrazolopyridinderivate
JP2004525150A (ja) * 2001-03-30 2004-08-19 スミスクライン ビーチャム コーポレーション 治療用化合物としてのピラゾロピリジン類の使用
WO2002078700A1 (en) 2001-03-30 2002-10-10 Smithkline Beecham Corporation Pyralopyridines, process for their preparation and use as therapteutic compounds
ATE332301T1 (de) * 2001-04-10 2006-07-15 Smithkline Beecham Corp Antivirale pyrazolopyridin verbindungen
EP1385847B1 (en) * 2001-04-27 2005-06-01 SmithKline Beecham Corporation Pyrazolo[1,5-a]pyridine derivatives
AUPR548601A0 (en) * 2001-06-06 2001-06-28 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyrazinecompound and pharmaceutical use thereof
PL366827A1 (en) * 2001-06-21 2005-02-07 Smithkline Beecham Corporation Imidazo[1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
DE60220525T2 (de) * 2001-09-07 2008-02-07 Smithkline Beecham Corp. Pyrazolo-pyridine für die behandlung von herpes-ansteckungen
ATE326466T1 (de) * 2001-10-05 2006-06-15 Smithkline Beecham Corp Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
ES2292839T3 (es) * 2001-12-11 2008-03-16 Smithkline Beecham Corporation Derivados de pirazolo-piridina como agentes contra el herpes.
JP2006504728A (ja) * 2002-10-03 2006-02-09 スミスクライン ビーチャム コーポレーション ピラソロピリジン誘導体系治療用化合物
BRPI0712381A2 (pt) * 2006-06-06 2012-07-10 Avigen Inc compostos de pirazolo[1,5-a]piridina substituìda e seus métodos de uso
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
GB8901423D0 (en) * 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Европейская заявка N 299209, кл. C 07 D 471/04, 1989. Европейская заявка N 0121297, кл. C 07 D 471/04, 1984. Европейская заявка N 0121806, кл. C 07 D 471/04, 1984. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2235725C2 (ru) * 1998-04-29 2004-09-10 Астразенека Аб Производные имидазопиридина, способ их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты и способ лечения состояний, в которые вовлечено инфицирование h.pylori
RU2238271C2 (ru) * 1998-04-29 2004-10-20 Астразенека Аб Производные имидазопиридина, способы их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которых вовлечено инфицирование h.pylori

Also Published As

Publication number Publication date
CN1041203C (zh) 1998-12-16
AU1398892A (en) 1992-10-15
AU653007B2 (en) 1994-09-15
TW205550B (enExample) 1993-05-11
NO921413D0 (no) 1992-04-09
KR100248700B1 (ko) 2000-08-01
FI100969B (fi) 1998-03-31
EP0516941A1 (en) 1992-12-09
IL101544A (en) 1996-06-18
UA27252C2 (uk) 2000-08-15
GR3022113T3 (en) 1997-03-31
IL101544A0 (en) 1992-12-30
US5234930A (en) 1993-08-10
FI921522A0 (fi) 1992-04-07
DK0516941T3 (da) 1997-01-06
MX9201672A (es) 1992-10-01
DE69215965T2 (de) 1997-04-10
CN1067427A (zh) 1992-12-30
CN100508975C (zh) 2009-07-08
JP2903040B2 (ja) 1999-06-07
FI921522L (fi) 1992-10-11
CN1205205A (zh) 1999-01-20
EP0516941B1 (en) 1996-12-18
DE69215965D1 (de) 1997-01-30
HU211680A9 (en) 1995-12-28
HU214871B (hu) 1998-07-28
JP2546470B2 (ja) 1996-10-23
JPH08208650A (ja) 1996-08-13
JPH05112566A (ja) 1993-05-07
NO300271B1 (no) 1997-05-05
IE921086A1 (en) 1992-10-21
CA2065644A1 (en) 1992-10-11
HUT61300A (en) 1992-12-28
HU9201213D0 (en) 1992-07-28
ATE146473T1 (de) 1997-01-15
SG43917A1 (en) 1997-11-14
KR920019787A (ko) 1992-11-20
CA2065644C (en) 2002-12-03
GB9107513D0 (en) 1991-05-29
NO921413L (no) 1992-10-12
ES2095976T3 (es) 1997-03-01

Similar Documents

Publication Publication Date Title
RU2069662C1 (ru) Производные пиразоло [1,5-а] пиридина, или их фармацевтически приемлемые соли и способ их получения
US5773530A (en) Pyrazolopyridine adenosine antagonists
JP2703408B2 (ja) １，４‐ベンゾチアゼピン誘導体
JP3993651B2 (ja) シクロプロパクロメンカルボン酸誘導体
JPH06239822A (ja) 新規なｎ−ベンゾイルアミノ酸誘導体、これらの化合物を含有する医薬組成物およびこれらの化合物を製造する方法
JPH057386B2 (enExample)
EP0482939A1 (en) Isoquinolinone derivative
JP2000511173A (ja) 一酸化窒素産生阻害剤としての新規なインドリルおよびベンゾフラニルカルボキサミド
JPH0987282A (ja) チアゾール誘導体
JP2004502684A (ja) Ｃｏｍｔ阻害活性を有するクマリン誘導体
HK1000507A1 (en) Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
HK1000507B (en) Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
WO1997026242A1 (en) 3-(bis-substituted-phenylmethylene)oxindole derivatives
EP0326106A2 (en) Alkylene diamines
WO1993012110A1 (en) Benzopyran class iii antiarrhythmic agents
JP3748935B2 (ja) オキシインドール誘導体
EP0309261B1 (en) Butenoic acid amides, their salts, pharmaceutical compositions containing them and process for preparing same
JPH0680041B2 (ja) ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
ES2238015B1 (es) Derivados de cicloalcanodionas con actividad neuroprotectora.
JPH07603B2 (ja) イソキノリンスルホンアミド誘導体
CN117550997A (zh) 一种lat1抑制剂及其制法和应用
JPH0434541B2 (enExample)
WO1997046520A1 (fr) Derives de 4-nitro-2-phenoxysulfonanilides
JPH05339223A (ja) 三環式化合物
JPWO1997021691A1 (ja) チアゾール誘導体

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner